Intercept Pharmaceuticals sell BiotechBee
Start price
30.09.22
/
40%
€13.70
Target price
31.01.23
€9.00
Performance (%)
-12.08%
End price
03.01.23
€12.05
Summary
This prediction ended on 03.01.23 with a price of €12.05. The price of Intercept Pharmaceuticals decreased from the start of the prediction. Compared to the start price this resulted in a performance of -12.08%. BiotechBee has 40% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intercept Pharmaceuticals | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to BiotechBee what are the pros and cons of Intercept Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intercept Pharmaceuticals diskutieren
Sell mit Kursziel 10,0
Kursziel geändert auf 9,0
In the thread Trading Intercept Pharmaceuticals
Sell beendet
Stopped prediction by BiotechBee for Intercept Pharmaceuticals
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€16.65
20.09.22
20.09.22
€32.00
31.01.23
31.01.23
-17.72%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year